Knowledge, Attitudes, and Practices Associated with Pertussis Vaccination during Pregnancy: Japan, 2016–2017

Yahata, Yuichiro; Kamiya, Hajime; Griffith, Matthew; Tsuchihashi, Yuuki; Kawakami, Shoichi; Nii, Shigeru; Sunagawa, Tomimasa

doi:10.7883/yoken.jjid.2020.489

Cited by 1 publication

(2 citation statements)

References 16 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A lack of understanding of infectious diseases and their outcomes seems to be one of the reasons for the low rate of maternal vaccination in Japan 44 . During 2015–2018, Japan ranked the lowest among 149 countries in terms of confidence in vaccine safety, 45 which may explain the low vaccination coverage rates for pregnant women in Japan.…”

Section: Vaccine Hesitancy Among Pregnant Women and Factors Influenci...mentioning

confidence: 99%

“…A lack of understanding of infectious diseases and their outcomes seems to be one of the reasons for the low rate of maternal vaccination in Japan. 44 During 2015–2018, Japan ranked the lowest among 149 countries in terms of confidence in vaccine safety, 45 which may explain the low vaccination coverage rates for pregnant women in Japan. In a study that examined the decision to administer influenza vaccine to pregnant women despite it not being included in the routine vaccination schedule, a number of factors positively influenced vaccine uptake, including awareness of influenza vaccination, having received this vaccine in the past, recommendation for vaccination from an obstetrician, older age, longer education period, higher household income, and having other child/children.…”

Section: Vaccine Hesitancy Among Pregnant Women and Factors Influenci...mentioning

confidence: 99%

See 1 more Smart Citation

Maternal vaccination—current status, challenges, and opportunities

Kurasawa

2022

J of Obstet and Gynaecol

View full text Add to dashboard Cite

Aim Maternal vaccination is a promising strategy for protecting pregnant women and newborns against severe infections. This review aims to describe the current status and challenges associated with maternal vaccination against seasonal influenza, tetanus‐diphtheria‐pertussis (Tdap/DTaP), and novel coronavirus disease of 2019 (COVID‐19) in Japan and other countries, mainly the United States and the United Kingdom. Methods A literature search was conducted in PubMed and other public websites (e.g., Centers for Disease Control and Prevention) to obtain information on maternal vaccination. Results Inactivated vaccines are recommended for pregnant women by gynecologic societies in Japan, the United States, and the United Kingdom. Among pregnant Japanese women, the influenza and COVID‐19 (two doses) vaccine coverage rates were 27.0%–53.5% (six studies) and 73.6% (one study), respectively; there are no studies on maternal vaccination with DTaP. Concerns regarding vaccine safety are a major barrier to maternal vaccination across countries. Maternal vaccination is effective in preventing severe disease in pregnant women and protecting infants aged <6 months, is generally safe, and does not increase the risk of adverse maternal and fetal outcomes. Providing accurate information regarding vaccination through healthcare providers and the government and government funding for vaccines may help improve maternal vaccination rates in Japan. Conclusion Current coverage for maternal vaccination is still low globally mainly because of vaccine hesitancy among pregnant women. The government, drug‐regulatory authorities, and healthcare professionals must educate pregnant women about the effectiveness and safety of maternal vaccines and encourage vaccination when the benefits outweigh the risks.

show abstract

Section: Vaccine Hesitancy Among Pregnant Women and Factors Influenci...mentioning

confidence: 99%

Section: Vaccine Hesitancy Among Pregnant Women and Factors Influenci...mentioning

confidence: 99%